Matthias Stephan, MD, PhD: Moving beyond Chemotherapy
Years Funded: 2018-2021
Preventing Cancer Vaccine Failure via Nanoparticle-Mediated TCR Programming
A multi-disciplinary team of immunologists, bioengineers and geneticists led by Matthias Stephan, MD, PhD, at the Fred Hutchinson Cancer Research Center (Seattle, WA) is advancing new strategies for fostering the effectiveness of anti-cancer vaccines in broad patient populations by combining principles of bioengineering and gene therapy.